UC Irvine CIRM Institute
The Stem Cell Research Program will build upon a long history of achievement in regeneration and developmental biology. Program scientists have made key contributions to developing stem cells, understanding how…
The Stem Cell Research Program will build upon a long history of achievement in regeneration and developmental biology. Program scientists have made key contributions to developing stem cells, understanding how…
OVERVIEW: The CIRM Facility will support ~19K+ ASF of laboratory and vivarium not subject to federal human embryonic stem cell (hESC) restrictions including: 1) Research labs, 2) Core facilities, and…
The Stem Cell Center is a cornerstone program of campus biomedical research that capitalizes on our strengths in basic and preclinical research, as well as collaborations with neighboring research institutions,…
The proposed new CIRM Stem Cell Institute, to be located at a major public university, will be the center of scientific and clinical activity to bring stem cell therapies to…
The San Diego Consortium for Regenerative Medicine (“SDCRM”) is a nonprofit organization formed to marshal the intellectual resources of four world-leaders in life sciences research, including the Burnham Institute for…
This application will describe the depth and breadth of our Stem Cell Programs in the “CIRM Institute” category. We are requesting funds to help with the construction costs for our…
Facility The Buck Institute for Age Research proposes to develop a CIRM Major Facility to investigate the role of stem cells in aging and in the pathogenesis, diagnosis and treatment…
Many fetuses with congenital blood stem cell disorders such as sickle cell disease or thalassemia are prenatally diagnosed early enough in pregnancy to be treated with stem cell transplantation. The…
Because the regenerative capacity of adult heart is limited, any substantial cell loss as a result of a heart attack is mostly irreversible and may lead to progressive heart failure.…
Despite therapeutic advances, cardiovascular disease remains a leading cause of mortality and morbidity in California. Regenerative therapies that restore normal function after a heart attack would have an enormous societal…